These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 223175)

  • 1. Effects of labetalol on lipid and carbohydrates metabolism.
    Pagnan A; Pessina AC; Hlede M; Zanetti G; Dal Palu' C
    Pharmacol Res Commun; 1979 Mar; 11(3):227-36. PubMed ID: 223175
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol.
    Andersson O; Berglund G; Hansson L
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):757-61. PubMed ID: 1032990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol and lipids.
    McGonigle RJ; Williams L; Murphy MJ; Parsons V
    Lancet; 1981 Jan; 1(8212):163. PubMed ID: 6109848
    [No Abstract]   [Full Text] [Related]  

  • 4. Labetalol in hypertension.
    Raftery EB
    Lancet; 1977 Jun; 1(8024):1269. PubMed ID: 68378
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of labetalol on the response of arterial blood pressure to exercise in hypertensive patients].
    Wajngarten M; Antunes JE; Pereyra PL; Godoy M; Dauar D; Martinelli Filho M; Pereira Barretto AC; Pileggi F
    Arq Bras Cardiol; 1983 Jan; 40(1):65-7. PubMed ID: 6615264
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of labetalol and oxprenolol on blood lipids.
    Sommers DK; de Villiers LS; van Wyk M; Schoeman HS
    S Afr Med J; 1981 Sep; 60(10):379-80. PubMed ID: 7025257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reduction of blood pressure with acute oral labetalol.
    Davies AB; Bala Subramanian V; Gould B; Raftery EB
    Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of primary hyperlipoproteinemias. 3. Disturbances in the carbohydrate metabolism.
    Ciświcka-Sznajderman M
    Pol Med J; 1972; 11(2):244-9. PubMed ID: 4341945
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Br J Clin Pharmacol; 1981 Sep; 12(3):349-53. PubMed ID: 7295465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins, glucose tolerance and insulin response in primary gout.
    Wiedemann E; Rose HG; Schwartz E
    Am J Med; 1972 Sep; 53(3):299-307. PubMed ID: 5054722
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension.
    Haenni A; Lithell H
    Metabolism; 1994 Apr; 43(4):455-61. PubMed ID: 8159103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of different antihypertensive therapies on plasma lipids.
    Gomez G
    Practitioner; 1982 May; 226(1367):985-91. PubMed ID: 7100090
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.